FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3019471330> ?p ?o ?g. }

• W3019471330 endingPage "243" @default.
• W3019471330 startingPage "239" @default.
• W3019471330 abstract "The goal of this study was to assess the clinical performance of an investigational in vitro fecal calprotectin immunoassay for differentiating inflammatory bowel disease (IBD) from irritable bowel syndrome (IBS).Fecal calprotectin is a stool biomarker that can assist in the detection of intestinal inflammation and is utilized to identify individuals who have a higher chance of having IBD and who require further invasive tests. Current assays exhibit variable performance.This study was a multicenter, cross-sectional analysis of prospectively collected stool samples from patients 4 years of age or older who presented with gastrointestinal (GI) symptoms and underwent colonoscopy for diagnostic confirmation. IBD was diagnosed based on clinical, endoscopic, and histologic findings. IBS was diagnosed based on Rome III Criteria and negative colonoscopy. Stool samples were extracted and tested on the DiaSorin LIAISON XL using the LIAISON Calprotectin Assay.A total of 240 patients (67% female) were included in the study. In total, 102 patients had IBD (54% ulcerative colitis), 67 had IBS, and 71 had other GI disorders. Median fecal calprotectin levels were significantly higher in patients with IBD [522 μg/g; 95% confidence interval (CI): 354-970 μg/g] compared with IBS (34.5 μg/g; 95% CI: 19.7-44.2 μg/g, P<0.001) and other GI disorders (28.6 μg/g; 95% CI: 18.7-40.3 μg/g, P<0.001). Receiver operating characteristic curve analysis indicated a fecal calprotectin cutoff of 94 μg/g for distinguishing IBD from other GI disorders with an area under the curve of 0.964 (sensitivity=92.2%, specificity=88.4%).The automated LIAISON Calprotectin assay brings efficient calprotectin testing to the laboratory with a time to the first result of 35 minutes and is a sensitive marker for distinguishing IBD from IBS with a cutoff of ∼100 μg/g." @default.
• W3019471330 created "2020-05-01" @default.
• W3019471330 creator A5000629386 @default.
• W3019471330 creator A5031682391 @default.
• W3019471330 creator A5047880347 @default.
• W3019471330 creator A5064983089 @default.
• W3019471330 creator A5082544726 @default.
• W3019471330 date "2020-04-21" @default.
• W3019471330 modified "2023-09-30" @default.
• W3019471330 title "Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome" @default.
• W3019471330 cites W1998046996 @default.
• W3019471330 cites W2047061163 @default.
• W3019471330 cites W2061541282 @default.
• W3019471330 cites W2068522893 @default.
• W3019471330 cites W2069921868 @default.
• W3019471330 cites W2105857910 @default.
• W3019471330 cites W2120579537 @default.
• W3019471330 cites W2159449574 @default.
• W3019471330 cites W2171495193 @default.
• W3019471330 cites W2284831904 @default.
• W3019471330 cites W2332839724 @default.
• W3019471330 cites W2460412619 @default.
• W3019471330 cites W2524585456 @default.
• W3019471330 cites W2565234044 @default.
• W3019471330 cites W2566199716 @default.
• W3019471330 cites W2587755289 @default.
• W3019471330 cites W2590800515 @default.
• W3019471330 cites W2604490502 @default.
• W3019471330 cites W2737208830 @default.
• W3019471330 cites W2757450823 @default.
• W3019471330 cites W2766230215 @default.
• W3019471330 cites W2790472648 @default.
• W3019471330 cites W2891128543 @default.
• W3019471330 doi "https://doi.org/10.1097/mcg.0000000000001359" @default.
• W3019471330 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7960147" @default.
• W3019471330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32324678" @default.
• W3019471330 hasPublicationYear "2020" @default.
• W3019471330 type Work @default.
• W3019471330 sameAs 3019471330 @default.
• W3019471330 citedByCount "9" @default.
• W3019471330 countsByYear W30194713302020 @default.
• W3019471330 countsByYear W30194713302021 @default.
• W3019471330 countsByYear W30194713302022 @default.
• W3019471330 countsByYear W30194713302023 @default.
• W3019471330 crossrefType "journal-article" @default.
• W3019471330 hasAuthorship W3019471330A5000629386 @default.
• W3019471330 hasAuthorship W3019471330A5031682391 @default.
• W3019471330 hasAuthorship W3019471330A5047880347 @default.
• W3019471330 hasAuthorship W3019471330A5064983089 @default.
• W3019471330 hasAuthorship W3019471330A5082544726 @default.
• W3019471330 hasBestOaLocation W30194713301 @default.
• W3019471330 hasConcept C121608353 @default.
• W3019471330 hasConcept C126322002 @default.
• W3019471330 hasConcept C151730666 @default.
• W3019471330 hasConcept C185592680 @default.
• W3019471330 hasConcept C2778260677 @default.
• W3019471330 hasConcept C2778271842 @default.
• W3019471330 hasConcept C2778292693 @default.
• W3019471330 hasConcept C2778435480 @default.
• W3019471330 hasConcept C2779008522 @default.
• W3019471330 hasConcept C2779134260 @default.
• W3019471330 hasConcept C2780479503 @default.
• W3019471330 hasConcept C2781197716 @default.
• W3019471330 hasConcept C526805850 @default.
• W3019471330 hasConcept C55493867 @default.
• W3019471330 hasConcept C61716771 @default.
• W3019471330 hasConcept C71924100 @default.
• W3019471330 hasConcept C86803240 @default.
• W3019471330 hasConcept C90924648 @default.
• W3019471330 hasConceptScore W3019471330C121608353 @default.
• W3019471330 hasConceptScore W3019471330C126322002 @default.
• W3019471330 hasConceptScore W3019471330C151730666 @default.
• W3019471330 hasConceptScore W3019471330C185592680 @default.
• W3019471330 hasConceptScore W3019471330C2778260677 @default.
• W3019471330 hasConceptScore W3019471330C2778271842 @default.
• W3019471330 hasConceptScore W3019471330C2778292693 @default.
• W3019471330 hasConceptScore W3019471330C2778435480 @default.
• W3019471330 hasConceptScore W3019471330C2779008522 @default.
• W3019471330 hasConceptScore W3019471330C2779134260 @default.
• W3019471330 hasConceptScore W3019471330C2780479503 @default.
• W3019471330 hasConceptScore W3019471330C2781197716 @default.
• W3019471330 hasConceptScore W3019471330C526805850 @default.
• W3019471330 hasConceptScore W3019471330C55493867 @default.
• W3019471330 hasConceptScore W3019471330C61716771 @default.
• W3019471330 hasConceptScore W3019471330C71924100 @default.
• W3019471330 hasConceptScore W3019471330C86803240 @default.
• W3019471330 hasConceptScore W3019471330C90924648 @default.
• W3019471330 hasIssue "3" @default.
• W3019471330 hasLocation W30194713301 @default.
• W3019471330 hasLocation W30194713302 @default.
• W3019471330 hasLocation W30194713303 @default.
• W3019471330 hasLocation W30194713304 @default.
• W3019471330 hasOpenAccess W3019471330 @default.
• W3019471330 hasPrimaryLocation W30194713301 @default.
• W3019471330 hasRelatedWork W1992704134 @default.
• W3019471330 hasRelatedWork W2014340860 @default.
• W3019471330 hasRelatedWork W2102384908 @default.
• W3019471330 hasRelatedWork W2158160762 @default.

• next